ClearSight Therapeutics

ClearSight Therapeutics is commercializing a first-in-class ocular surface protection platform designed to transform OTC eye care. With exclusive access to a critical supply chain, two commercial LOIs representing up to $84 million in potential five-year demand, and established commercialization relationships ahead of launch, ClearSight offers a compelling combination of innovation, market validation, and capital-efficient growth.